PDZK1 induces resistance to apoptosis in esophageal adenocarcinoma cells-Reference-Cited by-同舟云学术

PDZK1 induces resistance to apoptosis in esophageal adenocarcinoma cells

Published:2021-02-14 Issue:3 Volume:18 Page:655-662
ISSN:1612-9059
Container-title:Esophagus
language:en
Short-container-title:Esophagus

Author:

Handa Osamu^ORCID,Goda Kyousuke,Handa Yukiko,Fukushima Shinya,Osawa Motoyasu,Murao Takahisa,Matsumoto Hiroshi,Umegaki Eiji,Fujita Yoshihiko,Nishio Kazuto,Shiotani Akiko

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s10388-021-00819-z.pdf

Reference33 articles.

1. Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M, Are C. Global trends in esophageal cancer. J Surg Oncol. 2017;115(5):564–79. https://doi.org/10.1002/jso.24592.

2. Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63(4):232–48. https://doi.org/10.3322/caac.21185.

3. Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, et al. Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8(1):4522. https://doi.org/10.1038/s41598-018-19819-8.

4. Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture. Japan J Gastroenterol. 2018;53(7):827–33. https://doi.org/10.1007/s00535-017-1412-4.

5. Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am. 2015;44(2):203–31. https://doi.org/10.1016/j.gtc.2015.02.001.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism;Cell Division;2024-03-26

2. A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma;Frontiers in Oncology;2022-01-17